192 related articles for article (PubMed ID: 30088231)
1. hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression.
Sobecka A; Blaszczak W; Barczak W; Golusinski P; Rubis B; Masternak MM; Suchorska WM; Golusinski W
J Appl Genet; 2018 Nov; 59(4):453-461. PubMed ID: 30088231
[TBL] [Abstract][Full Text] [Related]
2. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
Guilleret I; Benhattar J
Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
[TBL] [Abstract][Full Text] [Related]
3. hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer.
Barczak W; Suchorska WM; Sobecka A; Bednarowicz K; Machczynski P; Golusinski P; Rubis B; Masternak MM; Golusinski W
Mol Med Rep; 2017 Jul; 16(1):441-446. PubMed ID: 28535013
[TBL] [Abstract][Full Text] [Related]
4. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia.
Bechter OE; Eisterer W; Dlaska M; Kühr T; Thaler J
Exp Hematol; 2002 Jan; 30(1):26-33. PubMed ID: 11823034
[TBL] [Abstract][Full Text] [Related]
5. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
Chen X; Liu L; Mims J; Punska EC; Williams KE; Zhao W; Arcaro KF; Tsang AW; Zhou X; Furdui CM
Epigenetics; 2015; 10(6):545-61. PubMed ID: 25961636
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity, telomere length and hTERT DNA methylation in peripheral blood mononuclear cells from monozygotic twins with discordant smoking habits.
Marcon F; Siniscalchi E; Andreoli C; Allione A; Fiorito G; Medda E; Guarrera S; Matullo G; Crebelli R
Environ Mol Mutagen; 2017 Oct; 58(8):551-559. PubMed ID: 28843010
[TBL] [Abstract][Full Text] [Related]
7. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
Devereux TR; Horikawa I; Anna CH; Annab LA; Afshari CA; Barrett JC
Cancer Res; 1999 Dec; 59(24):6087-90. PubMed ID: 10626795
[TBL] [Abstract][Full Text] [Related]
9. CpG islands in MyD88 and ASC/PYCARD/TMS1 promoter regions are differentially methylated in head and neck squamous cell carcinoma and primary lung squamous cell carcinoma.
Šutić M; Baranašić J; Bilić LK; Bilić M; Jakovčević A; Brčić L; Seiwerth S; Jakopović M; Samaržija M; Zechner U; Knežević J
Diagn Pathol; 2021 Feb; 16(1):17. PubMed ID: 33637109
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Guilleret I; Yan P; Grange F; Braunschweig R; Bosman FT; Benhattar J
Int J Cancer; 2002 Oct; 101(4):335-41. PubMed ID: 12209957
[TBL] [Abstract][Full Text] [Related]
11. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
[TBL] [Abstract][Full Text] [Related]
12. Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP.
Nomoto K; Maekawa M; Sugano K; Ushiama M; Fukayama N; Fujita S; Kakizoe T
Jpn J Clin Oncol; 2002 Jan; 32(1):3-8. PubMed ID: 11932355
[TBL] [Abstract][Full Text] [Related]
13. The correlation between CpG island methylation of hTERT promoter and human age prediction.
Cui H; Xin Y; Cao F; Gan Z; Tian Y; Liu W; Shi P
Leg Med (Tokyo); 2023 Jul; 63():102270. PubMed ID: 37207612
[TBL] [Abstract][Full Text] [Related]
14. Zinc sulfate contributes to promote telomere length extension via increasing telomerase gene expression, telomerase activity and change in the TERT gene promoter CpG island methylation status of human adipose-derived mesenchymal stem cells.
Farahzadi R; Fathi E; Mesbah-Namin SA; Zarghami N
PLoS One; 2017; 12(11):e0188052. PubMed ID: 29145503
[TBL] [Abstract][Full Text] [Related]
15. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.
Choi JH; Park SH; Park J; Park BG; Cha SJ; Kong KH; Lee KH; Park AJ
Biochem Biophys Res Commun; 2007 Sep; 361(3):615-20. PubMed ID: 17673177
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the human telomerase gene CpG island.
Dessain SK; Yu H; Reddel RR; Beijersbergen RL; Weinberg RA
Cancer Res; 2000 Feb; 60(3):537-41. PubMed ID: 10676632
[TBL] [Abstract][Full Text] [Related]
17. Anti-aging protective effect of L-carnitine as clinical agent in regenerative medicine through increasing telomerase activity and change in the hTERT promoter CpG island methylation status of adipose tissue-derived mesenchymal stem cells.
Farahzadi R; Fathi E; Mesbah-Namin SA; Zarghami N
Tissue Cell; 2018 Oct; 54():105-113. PubMed ID: 30309499
[TBL] [Abstract][Full Text] [Related]
18. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
[TBL] [Abstract][Full Text] [Related]
19. Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review).
Avin BA; Umbricht CB; Zeiger MA
Int J Oncol; 2016 Dec; 49(6):2199-2205. PubMed ID: 27779655
[TBL] [Abstract][Full Text] [Related]
20. Adipose Tissue-Mesenchymal Stem Cells Caused to Change the Methylation Status of
Fathi E; Montazersaheb S; Vandghanooni S; Farahzadi R; Vietor I
Curr Mol Med; 2023; 23(3):266-274. PubMed ID: 35040412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
